Another panellist at the IDF 2025 session, Professor Juliana Chan (China), offered a broader perspective by comparing old and newer diabetes medications
The benzyl alcohol prevents bacterial growth in multi-dose vials after initial needle puncture, allowing multiple withdrawals over a 28-day period when stored according to guidelines
They do not replace individualized medical evaluation or treatment
Nature 434 , 658662 (2005)
Independent Licensed Clinicians - contracted through affiliated professional entities including OpenLoop Health and CareGLP Affiliated P.C.s, according to MEDVi's published footer disclosures - review your health information and make the prescribing decision
FDA Approves DECNUPAZTM (pivekimab sunirine-pvzy) for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options DECNUPAZ is the first and only antibody-drug conjugate (ADC) approved for blastic plasmacytoid dendritic cell neoplasm (BPDCN) that is initiated in an outpatient setting DECNUPAZ marks AbbVies first ADC approved for blood cancer NORTH CHICAGO, Ill., May 27, 2026 /PRNewswire/ Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks To view or add a comment, sign in We've achieved 82% stable disease per RECIST, with 9 of 11 evaluable patients achieving stable disease, including one patient maintaining stable disease for over 15 months and another for 12 months
